A Randomized Trial of Yogurt for Prevention of Antibiotic-Associated Diarrhea

Digestive Diseases and Sciences

Volumn 48, Issue 10, 2003, Pages 2077-2082

  Beniwal, Ripudaman S ^a,d   Arena, Vincent C ^b   Thomas, Leno ^c   Narla, Sudhir ^c   Imperiale, Thomas F ^a   Chaudhry, Rauf A ^c   Ahmad, Usman A ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c USA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibiotic associated diarrhea; Biotherapeutics; Dietary intervention; Effectiveness; Prophylaxis; Yogurt

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN; YOGHURT;

ADULT; AGED; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLON FLORA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GASTROINTESTINAL MUCOSA; HOSPITALIZATION; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DIARRHEA; FEMALE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; YOGURT;

EID: 0242403368     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026155328638     Document Type: Article

References (27)

1. McFarland LV: Risk factors for antibiotic-associated diarrhea. A review of literature. Ann Med Intern 149(5):261-266, 1998
2. McFarland LV: Epidemiology, risk factors and treatment for antibiotic-associated diarrhea. Dig Dis 16(5):292-307, 1998
3. Wistrom J, Norrby SR, Myhre EB, et al: Frequency of antibiotic- associated diarrhea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47(1):43-50, 2001
4. Bartlett JG: Pseudomembranous enterocolitis and antibiotic-associated colitis. In MH Sleisinger, JS Fordtran (eds.) Grastrointestinal Diseases; 5th ed. Philadelphia, WB Saunders, 1993, pp 1174-1185
5. Hogenauer C, Hammer HF, Krejs GJ, et al: Mechanism and management of antibiotic-associated diarrhea. Clin Infect Dis 27:702-710, 1998
6. Wilcox MH, Cunniffe JG, Trundle C, et al: Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34:23-30, 1996
7. MacGowan AP, Brown I, Feeney R. et al: Clostridium difficile associated diarrhea and length of hospital stay. J Hosp Infect 31:241-44, 1995
8. Elmer GW, Surawicz CM, McFarland LV: Biotherapeutic agents - a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275(11):870-76, 1996
9. Minitab User's Guide: Release 13 for Windows. Minitab, Inc. 1999
10. Cytel: StatXact 4 Windows User Manuals. Cytel Software Corporation, Cambridge, Massachusetts, 1999
11. Gotz V, Romankiewicz JA, Moss J, et al: Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation. Am J Hosp Pharm 36:754-757, 1979
12. Anon: Bacid, Lactinex and yogurt. Med. Letter Drug Ther 14:59-60, 1972
13. Colombel JF, Cortot A, Neut C, et al: Yogurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 2:43, 1987
14. Vanderhoof JA, Whitney DB, Antonson DL, et al: Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Paediatr 135(5):564-8, 1999
15. Armuzzi A, Cremonin F, Bartolozzi F, et al: The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori therapy. Aliment Pharmacol Ther 15(2): 163-169, 2001
16. Witsell DL, Garrett G, Yarbrough WG, et al: Effect of Lactobacillus acidophilus on antibiotic associated gastrointestinal morbidity. Prospective randomized trial. J Otolaryngol (24) 230-233, 1995
17. Lidbeck A, Edlund C, Gustafsson JA, et al: Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents. Infection 16(6):329-36, 1988
18. Malin M, Suomalainen H, Saxelin M, et al: Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 40:137-45, 1996
19. Madsen KL, Tavenini MM, Doyle JSG, et al: Interleukin-10 gene deficient mice demonstrate a primary defect in IgA secretion. Gastroenty 112:A1031, 1997
20. Kruis W, Schultz E, Fric P, et al: Double-blind comparison of an oral Escherichia coli preparation and mesalamine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11:853-8, 1997
21. Gionchetti P, Rizzello F, Matteuzzi D, et al: Microflora in IBD pathogenesis. Possible therapeutic role of probiotics. Gastroenterol Int 11:108-11, 1998
22. Surawicz CM, Elmer GW, Speelman P, et al: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology 96:981-8, 1989
23. Biller JA, Katz AJ, Flores AF: Treatment of recurrent C. difficile colitis with Lactobacillus GG. J Pediatr. Gastroenterol Nutr 21:224-226, 1995
24. Gorbach SL, Chang T, Goldin B: Successful treatment of relapsing Clostridium colitis with Lactobacillus GG. Lancet 2:1519, 1987
25. Pochapin M: The effect of probiotics on Clostridium difficle diarrhea. Am J. Gastroenterol 95(1):S11-14, 2000
26. Hrobjartsson A, Gotzsche PC: Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. NEJM 344(21):1594-1602, 2001
27. Bartlet JG: Antibiotic-associated diarrhea. NEJM 346(5):334-339, 2002